Related Experiment Video

Updated: Jan 17, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Toward Clinical Implementation of a Volumetric Absorptive Microsampling-Based Method for Dasatinib and Imatinib

Nick Verougstraete^1,2, Dominiek Mazure³, Christophe P Stove¹

¹Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Therapeutic Drug Monitoring

|September 18, 2025

Abstract

Background:

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors may improve treatment outcomes and individualized therapy in patients with cancer. Compared with plasma, the standard TDM matrix, dried blood microsampling is associated with several advantages, including the collection of samples by the patients themselves in their home setting. This study aimed to compare dasatinib and imatinib concentrations in different blood-based matrices and to determine whether dried capillary blood collected via volumetric absorptive microsampling (VAMS) could be used as an alternative to perform TDM in patients with chronic myeloid leukemia.

Methods:

In addition to venous liquid whole blood, plasma, and VAMS samples (referred to as venous VAMS) prepared thereof, also fingerprick capillary VAMS samples were collected from patients receiving dasatinib or imatinib treatment by skilled personnel in a controlled environment. All samples were analyzed using validated liquid chromatography tandem mass spectrometry methods.

Results:

Fifty-three patients were included in the study: 33 were treated with dasatinib and 20 with imatinib. Although a bias between dasatinib and imatinib venous VAMS and liquid blood concentrations was observed, 94% and 95% of the samples, respectively, fulfilled the 20% difference acceptance criterion. Capillary and venous concentrations were interchangeable and independent of the collection time. Using venous blood-to-plasma ratios from a prior proof-of-concept study, the VAMS results for imatinib, but not dasatinib, could reliably be converted into plasma concentrations.

Conclusions:

Through a clinical validation study, the authors demonstrated that VAMS is a viable alternative for imatinib monitoring in patients with chronic myeloid leukemia. For dasatinib, VAMS-based analysis may still allow for longitudinal follow-up (ie, provide insight into fluctuations in patients). As a next step, capillary microsampling can be integrated into the home sampling context.

Keywords:

chronic myeloid leukemia therapeutic drug monitoring tyrosine kinase inhibitors volumetric absorptive microsampling

More Related Videos

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Methods for Studying Drug Absorption: In situ

Methods for Studying Drug Absorption: In situ

In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...

Methods for Studying Drug Absorption: In vitro

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

Articles linked to this work by shared authors, journal, and citation graph.

In Silico to In Cerebro-Development of the Orexin Receptor Antagonist "Photorexant" for Photomodulation In Vitro and in Mouse Brains.

Angewandte Chemie (International ed. in English)·2026

Do assay parameters affect the inter-assay comparability of cannabinoid CB₁ receptor affinity and activation measurements?

Toxicology and applied pharmacology·2026

Reference values for the alcohol biomarker phosphatidylethanol (PEth) in the Belgian population: Insights from a nationwide microsampling study.

Drug and alcohol dependence reports·2026

Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances.

Molecules (Basel, Switzerland)·2026

Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligence.

Frontiers in pharmacology·2026

Analytical validation of a dried blood microsampling method to measure androstenedione, 17α‑hydroxyprogesterone, and 11‑ketotestosterone for congenital adrenal hyperplasia monitoring.

Talanta·2026

See all related articles